[{"data":1,"prerenderedAt":440},["ShallowReactive",2],{"slug-pharma-companies-and-digital-transformation":3},{"post":4,"relatedPosts":193,"relatedBooks":349},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":38,"project_category":48,"contact_email_category":51,"yst_prominent_words":52,"class_list":70,"better_featured_image":95,"acf":128,"yoast_meta":137,"_links":140},33895,"2021-04-15T10:00:00","2021-04-15T08:00:00",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=33895&_wpnonce=640dc9b8b2&status=auto-draft&type=post","2021-09-16T11:04:36","2021-09-16T09:04:36","pharma-companies-and-digital-transformation","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fpharma-companies-and-digital-transformation",{"rendered":17},"Why Pharma Companies Must Stop Saying ‘Digital Transformation’",{"rendered":19,"protected":20},"\n\u003Cp>From education to lunch ordering, from work to dating, talking about “digital” has changed these past months – everything is online. Our entire social network has transformed to such depths that it will be a long time to assess its effects. The operation of entire industries has changed, and, of course, healthcare is no exception. And although we have heard of the digital transformation in medicine for years now, what exactly it covers remains unclear.\u003C\u002Fp>\n\n\n\n\u003Cp>I have worked with over 30 different pharmaceutical companies over the past 15 years, giving 100+ keynote speeches around the world live and online. Each one of them explained how they want to transform a conventional company through an organisational course towards a digital switchover. They all say:\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\u003Cli>“\u003Cem>We are a conservative company.\u003C\u002Fem>”\u003C\u002Fli>\u003Cli>“\u003Cem>We are going through an organisational journey\u002Fchange.”\u003C\u002Fem>\u003C\u002Fli>\u003Cli>“\u003Cem>We want to embrace digital transformation.\u003C\u002Fem>”\u003C\u002Fli>\u003C\u002Fol>\n\n\n\n\u003Cp>Based on these challenges, they often ask me to talk about the digital transformation and its direct impact on healthcare in my speeches. But I need to be honest: \u003Cstrong>I don’t know what they mean by it\u003C\u002Fstrong>. Let me explain why.\u003C\u002Fp>\n\n\n\n\u003Cp>The healthcare industry is already using a gazillion of digital solutions. Medical professionals are actively using digital technologies, from mobile communications, telehealth solutions and digital analytics to chatbots and A.I. As such, medicine is going through a similar transformational journey as for example the banking sector did. Pharma companies feel the need to participate in this venture. \u003C\u002Fp>\n\n\n\n\u003Cp>It only makes sense to challenge them if it’s a way of \u003Cem>working\u003C\u002Fem> or a way of \u003Cem>thinking\u003C\u002Fem>.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-768x432.png\" alt=\"\" class=\"wp-image-28737\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>What IS digital transformation?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>I consider myself a geek and I know how it is to live with data. My entire life is filled with technology, covering most facets of my life. I use technology, write about it, analyse reports and publish studies about it. I build my own PC and have been active on most digital channels for years. And still. I wouldn’t call this digital transformation. \u003C\u002Fp>\n\n\n\n\u003Cp>But then again, what is it? \u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-pullquote\">\u003Cblockquote>\u003Cp>\u003Cstrong>What do pharma executives mean when they talk about digital transformation?\u003C\u002Fstrong> \u003C\u002Fp>\u003C\u002Fblockquote>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-center\">Would they mean \u003Cbr>that pharma representatives who go to see doctors \u003Cbr>can also send them information through a digital channel?\u003C\u002Fp>\n\n\n\n\u003Cp class=\"has-text-align-center\">Would they mean \u003Cbr>all pharma employees should use a health tech that their consumers use\u003Cbr>to better understand what they are going through (e.g. a health sensor or smartwatch for a healthier life)?\u003C\u002Fp>\n\n\n\n\u003Cp class=\"has-text-align-center\">Would they mean\u003Cbr>all elements of the supply chain \u003Cbr>to be accessed, verified and analysed as digital data? \u003C\u002Fp>\n\n\n\n\u003Cp class=\"has-text-align-center\">Or can they mean all drug purchases to be tracked at the data level,\u003Cbr>and used to make better decisions with algorithms – right from drug design?\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F02\u002Fpharma-future-small-768x432.png\" alt=\"future of pharma\" class=\"wp-image-26469\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F02\u002Fpharma-future-small-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F02\u002Fpharma-future-small-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F02\u002Fpharma-future-small-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F02\u002Fpharma-future-small-512x288.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F02\u002Fpharma-future-small.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Trends shifting healthcare and pharma\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>There are certain trends that are shaping the future of pharma. Patient design means patient inclusion in key decision-making processes. Integrating A.I. in drug development saves time and money, while 3D printing leads to personalised medicine. Automation supplements the supply chain with more effective solutions, from manufacturing processes to pill dispersion. We pointed out some of the most important changes in healthcare for pharmaceutical companies in \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Ftechnologies-shaping-the-future-of-pharma-e-book\u002F\" target=\"_blank\">this article\u003C\u002Fa> and in \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fleanpub.com\u002Fthefutureofpharma\" target=\"_blank\">our e-book\u003C\u002Fa>. \u003C\u002Fp>\n\n\n\n\u003Cp>This still isn’t digital transformation – these are steps towards; and pharma leaders need to see these technologies and solutions as such.\u003C\u002Fp>\n\n\n\n\u003Cp>And not all these changes are digital – they are logical. First of all, no change will come (but a bucketload of \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhy-national-digital-health-transformations-fail\">money wasted\u003C\u002Fa>) unless it is preceded by a cultural transformation. Moreover, there is a massive difference between health IT and digital health, and pharma executives tend to forget this fact. \u003C\u002Fp>\n\n\n\n\u003Cp>But, most importantly, none of the above, data, algorithms, sensors, devices, tools, robots, channels, A.I. and the rest of the so-called digital transformational accessories make sense unless understood more deeply and analysed as a strategic concept.\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Cp>\u003Cstrong>An attempted “digital transformation” will only be understood and executed if pharma companies define what exactly they mean by it in terms of leadership, value creation and vision. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Without that, this empty phrase keeps on being more destructive than forward-looking.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n",false,{"rendered":22,"protected":20},"\u003Cp>From education to lunch ordering, from work to dating, talking about “digital” has changed these past months – everything is online. Our entire social network […]\u003C\u002Fp>\n",6,33877,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31,32,33,34,35,36,37],504,521,490,499,497,494,514,[39,40,41,42,43,44,45,46,47],130,819,196,6937,821,275,6939,840,356,[49,50],947,953,[],[53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69],1683,1693,1571,1723,1577,1831,1593,1883,1609,2871,1611,3435,1613,6067,1625,1661,1681,[71,14,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94],"post-33895","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","category-future-medicine","category-future-of-pharma","category-healthcare-design","category-portable-diagnostics","category-telemedicine","category-virtual-reality","tag-3d-printing-2","tag-pharmaceutics","tag-data-2","tag-digital-transformation","tag-a-i","tag-healthcare","tag-digital-channels","tag-supply-chain","tag-pharma-2","project_category-company","project_category-researchers",{"id":24,"alt_text":96,"caption":27,"description":27,"media_type":97,"media_details":98,"post":126,"source_url":127},"TMF, drug, pharma","image",{"width":99,"height":100,"file":101,"sizes":102,"image_meta":124},1920,1080,"2021\u002F04\u002Ftmf_article_258-01.png",{"medium":103,"large":109,"thumbnail":114,"medium_large":118,"1536x1536":119},{"file":104,"width":105,"height":106,"mime-type":107,"source_url":108},"tmf_article_258-01-370x208.png","370","208","image\u002Fpng","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F04\u002Ftmf_article_258-01-370x208.png",{"file":110,"width":111,"height":112,"mime-type":107,"source_url":113},"tmf_article_258-01-768x432.png","768","432","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F04\u002Ftmf_article_258-01-768x432.png",{"file":115,"width":116,"height":116,"mime-type":107,"source_url":117},"tmf_article_258-01-150x150.png","150","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F04\u002Ftmf_article_258-01-150x150.png",{"file":110,"width":111,"height":112,"mime-type":107,"source_url":113},{"file":120,"width":121,"height":122,"mime-type":107,"source_url":123},"tmf_article_258-01-1536x864.png","1536","864","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F04\u002Ftmf_article_258-01-1536x864.png",{"aperture":125,"credit":27,"camera":27,"caption":27,"created_timestamp":125,"copyright":27,"focal_length":125,"iso":125,"shutter_speed":125,"title":27,"orientation":125},"0",33827,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F04\u002Ftmf_article_258-01.png",{"subtitle":27,"cta_type":129,"cta_color":27,"related_posts_footer":130,"related_posts":20,"related_books":134},"subscribe",[131,132,133],13650,14131,28943,[135,136],24764,31417,{"yoast_wpseo_title":138,"yoast_wpseo_metadesc":139,"yoast_wpseo_canonical":15},"Why Pharma Companies Must Stop Saying ‘Digital Transformation’ - The Medical Futurist","Pharma companies seek the term 'digital transformation' as the Holy Grail of the future of medicine. What exactly they mean by that is unclear.",{"self":141,"collection":147,"about":150,"author":153,"replies":156,"version-history":159,"predecessor-version":163,"wp:featuredmedia":167,"wp:attachment":170,"wp:term":173,"curies":189},[142],{"href":143,"targetHints":144},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F33895",{"allow":145},[146],"GET",[148],{"href":149},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[151],{"href":152},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[154],{"embeddable":26,"href":155},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F6",[157],{"embeddable":26,"href":158},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=33895",[160],{"count":161,"href":162},8,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F33895\u002Frevisions",[164],{"id":165,"href":166},36173,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F33895\u002Frevisions\u002F36173",[168],{"embeddable":26,"href":169},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F33877",[171],{"href":172},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=33895",[174,177,180,183,186],{"taxonomy":175,"embeddable":26,"href":176},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=33895",{"taxonomy":178,"embeddable":26,"href":179},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=33895",{"taxonomy":181,"embeddable":26,"href":182},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=33895",{"taxonomy":184,"embeddable":26,"href":185},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=33895",{"taxonomy":187,"embeddable":26,"href":188},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=33895",[190],{"name":191,"href":192,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[194],{"id":133,"date":195,"date_gmt":196,"guid":197,"modified":199,"modified_gmt":200,"slug":201,"status":13,"type":14,"link":202,"title":203,"content":205,"excerpt":207,"author":209,"featured_media":210,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":211,"categories":212,"tags":214,"project_category":228,"contact_email_category":233,"yst_prominent_words":234,"class_list":247,"better_featured_image":267,"acf":289,"yoast_meta":304,"_links":306},"2024-06-27T09:30:00","2024-06-27T07:30:00",{"rendered":198},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=28943&_wpnonce=d0d48c8f46&status=auto-draft&type=post","2024-06-26T17:55:58","2024-06-26T15:55:58","technologies-shaping-the-future-of-pharma-e-book","https:\u002F\u002Fmedicalfuturist.com\u002Ftechnologies-shaping-the-future-of-pharma-e-book",{"rendered":204},"Technologies Shaping The Future Of Pharma e-Book",{"rendered":206,"protected":20},"\n\u003Cp>Digital health is poised to bring its disruptive force across the healthcare landscape, and the pharmaceutical industry isn’t immune to the upcoming changes. Turning the point of care towards patients and empowering them with their health data, this \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdigital-health\u002F\" target=\"_blank\">cultural transformation\u003C\u002Fa> brings about a radical shift in the traditional functioning of the drug industry.\u003C\u002Fp>\n\n\n\n\u003Cp>In our latest e-book, the Medical Futurist team analyzed 11 major digital health technologies and practices with the greatest impact in this sector. From including patients in decision-making through personalized care to automating pharmaceutical processes, we compiled our findings in this new e-book. \u003C\u002Fp>\n\n\n\n\u003Cp>Those who embrace the paradigm shift that digital health brings about will be better prepared for the upcoming changes in pharma. Moreover, those companies will get a head start as compared to competitors.\u003Cstrong> To learn more, you can get your own copy of “Technologies Shaping The Future Of Pharma” on LeanPub below:\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large is-style-default\">\u003Ca class=\"img\" href=\"https:\u002F\u002Fleanpub.com\u002Fthefutureofpharma\" target=\"_blank\" rel=\"noopener\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-v2-copy-768x432.png\" alt=\"The Future Of Pharma ebook TMF 2022 edition\" class=\"wp-image-48039\"\u002F\u003C\u002Fa srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-v2-copy-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-v2-copy-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-v2-copy-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-v2-copy.png 1800w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Fa>\u003Cfigcaption class=\"wp-element-caption\">You can grab the book\u003Ca href=\"https:\u002F\u002Fleanpub.com\u002Fthefutureofpharma\" target=\"_blank\" rel=\"noreferrer noopener\"> on Leanpub\u003C\u002Fa>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>In this article, we share 5 take-home messages from the e-book that the new wave of digital health is bringing into pharma. If these pique your interest, we encourage you to dive deeper into these topics and more in the full e-book!\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>1. Patient inclusion in key decision-making processes improves deliverables in pharma\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>For as long as the drug industry has existed, patients’ roles have revolved solely as the end-user; destined to use products that were years in the making. However, all necessary steps before obtaining the finalized product happened within the heavily guarded doors of pharma’s ivory tower. With 21st-century technologies, these doors burst open and patients made their way into the proverbial tower.\u003C\u002Fp>\n\n\n\n\u003Cp>A prime example is that of the \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.healthline.com\u002Fhealth\u002Fdiabetesmine\u002Finnovation\u002Fwe-are-not-waiting#1\" target=\"_blank\">“#wearenotwaiting” movement\u003C\u002Fa> created by diabetics. \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Ffrom-patent-to-product-the-speed-of-the-digital-health-evolution\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Fed up with lagging regulations\u003C\u002Fa> that kept MedTech companies from introducing an artificial pancreas into the market, took matters into their own hands. Through online communities, they created such an \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fopenaps.org\u002F\" target=\"_blank\">open-sourced DIY pancreas\u003C\u002Fa>. They further built discussion platforms like \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.healthline.com\u002Fdiabetesmine\" target=\"_blank\">DiabetesMine\u003C\u002Fa> and cloud-based solutions like \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.tidepool.org\u002F\" target=\"_blank\">Tidepool\u003C\u002Fa> for more accessible and actionable diabetes data. Their initiative even forced the FDA’s hand to later approve \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.bloomberg.com\u002Fnews\u002Farticles\u002F2016-09-28\u002Fartificial-pancreas-approved-by-fda-is-first-such-device-in-u-s\" target=\"_blank\">the first commercial artificial pancreas\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas.png\" alt=\"\" class=\"wp-image-26721\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas.png 1920w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas-512x288.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F03\u002F071_artificial_pancreas-2048x1152.png 2048w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \u002F>\u003C\u002Ffigure>\n\u003C\u002Fdiv>\n\n\n\u003Cp>This exemplifies the need for pharma authorities to include patients in their decision-making processes. Through their input, their exact needs will be known and better products will be delivered to attend to these needs.\u003C\u002Fp>\n\n\n\n\u003Cp>“We support all of the companies working to commercialize a closed-loop system. We just wish they would each get their solution(s) to market more quickly!” – says the OpenAPS community FAQ, summarising the sentiment perfectly. \u003C\u002Fp>\n\n\n\n\u003Cp>It’s not enough to have patients fill out surveys as part of “patient centricity”. \u003Cstrong>What pharma companies need to adopt is patient design. \u003C\u002Fstrong>It goes beyond the passive act of asking about their opinion and actively involving them in crucial steps that will impact their health.\u003C\u002Fp>\n\n\n\n\u003Cp>In 2017, the FDA held its \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fda.gov\u002Fnews-events\u002Fpress-announcements\u002Fstatement-fda-commissioner-scott-gottlieb-md-new-steps-fda-advance-patient-engagement-agencys\" target=\"_blank\">first Patient Engagement Advisory Committee meeting\u003C\u002Fa>. It set the pace to involve patients in their regulatory activities. The European Federation of Pharmaceutical Industries and Associations (\u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.efpia.eu\u002Fabout-us\u002Fwho-we-are\u002F\" target=\"_blank\">EFPIA\u003C\u002Fa>) also took steps in this direction. It \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.efpia.eu\u002Fmedia\u002F24310\u002F3c_efpia-code-of-practice-on-relationships-pharmapluspt-orgs.pdf\" target=\"_blank\">developed a framework\u003C\u002Fa> to integrate patient organizations in their decision-making. Other members of the pharmaceutical industry could adopt similar strategies to better attend to their patients’ needs. In addition, such approaches will help deliver appropriate solutions faster.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>2. Integrating AI in drug development slashes time and cost\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>From finding suitable candidates for animal trials, from unexpected side effects in clinical trials to multiple trial-and-error sequences, drug development is understandably a lengthy and costly process. In fact, estimates put the numbers at about \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpmc\u002Farticles\u002FPMC1299137\u002F#:~:text=At%20present%2C%20bringing%20a%20single,progress%20from%20bench%20to%20market.\" target=\"_blank\">12 years\u003C\u002Fa> and an investment of \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F32125404\u002F\" target=\"_blank\">between $1 billion and $2.8 billion\u003C\u002Fa> for an experimental drug to advance from a lab to the market. Although last year’s median new drug prices \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.reuters.com\u002Fbusiness\u002Fhealthcare-pharmaceuticals\u002Fprices-new-us-drugs-rose-35-2023-more-than-previous-year-2024-02-23\u002F\" target=\"_blank\">were “only” $300,000\u003C\u002Fa>, the FDA approved five new drugs that had their development costs in the $1.8-3.2 billion range. \u003C\u002Fp>\n\n\n\n\u003Cp>However, developments in the field of artificial intelligence can help diminish the cost and time traditionally associated with drug development. To exemplify this possibility, Insilico Medicine, an AI pharma startup, identified a potential new drug \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.technologyreview.com\u002F2019\u002F09\u002F03\u002F133175\u002Fan-ai-system-identified-a-potential-new-drug-in-just-46-days\u002F\" target=\"_blank\">in only 46 days\u003C\u002Fa>. Its algorithm achieved this by analysing vast amounts of data, which would otherwise take humans years to go through. The drug didn’t result in a commercial one as this achievement was to prove the potential of AI in drug development. However, practical examples do exist within the industry.\u003C\u002Fp>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F11\u002F1018_TMF_AI_kiajanlo_003-768x432.png\" alt=\"\" class=\"wp-image-25289\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F11\u002F1018_TMF_AI_kiajanlo_003-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F11\u002F1018_TMF_AI_kiajanlo_003-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F11\u002F1018_TMF_AI_kiajanlo_003-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F11\u002F1018_TMF_AI_kiajanlo_003-512x288.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F11\u002F1018_TMF_AI_kiajanlo_003.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\u003C\u002Fdiv>\n\n\n\u003Cp>Merck forged AI drug-development collaborations with American-Israeli biotech company Biolojic Design and with U.S. company Caris Life Sciences. In September 2023, the company started working with U.K.-based AI specialists BenevolentAI and Exscientia, aiming to significantly reduce drug discovery timelines – \u003Ca href=\"https:\u002F\u002Fwww.wsj.com\u002Ftech\u002Fbiotech\u002Fgermanys-merck-bets-on-ai-drug-design-partnerships-rules-out-acquisitions-interview-943c5b7a\">The Wall Street Journal reported\u003C\u002Fa> in June 2024. \u003C\u002Fp>\n\n\n\n\u003Cp>Clinical trials alone are a vast field for AI, we \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fai-assistance-in-clinical-trials-the-practical-opportunities\" target=\"_blank\" rel=\"noreferrer noopener\">recently analysed this segment\u003C\u002Fa> and listed examples of how various algorithms can be used in pre-trial assistance, how they can support trials, and what they can do after the trials. Tools like \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-promise-of-crispr-gpt-specialized-chatgpts-could-transform-medicine\" target=\"_blank\" rel=\"noreferrer noopener\">CRISPR-GPT\u003C\u002Fa> can help us automate trial designs. \u003C\u002Fp>\n\n\n\n\u003Cp>In-silico platforms can predict real-world results with high accuracy. Novadiscovery’s jinkō \u003Ca href=\"https:\u002F\u002Fwww.novadiscovery.com\u002Fnovadiscovery-announces-success-of-first-of-its-kind-clinical-trial-simulation-to-accurately-predict-findings-of-phase-iii-clinical-study\u002F#:~:text=The%20jink%C5%8D%2Dpredicted%20findings%20were,a%20median%20TTP%20of%2025.9%20%5B\" target=\"_blank\" rel=\"noreferrer noopener\">predicted the results of an AstraZeneca trial\u003C\u002Fa> with about 97% accuracy before the company published the results. And it took three weeks to design, one hour to execute – and had a cost of a couple thousand dollars.\u003C\u002Fp>\n\n\n\n\u003Cp>To illustrate the speed of development, we only have to look around for some \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fphys.org\u002Fnews\u002F2021-12-scientists-unveil-drug-discovery-tool.html\" target=\"_blank\">existing good examples\u003C\u002Fa>. \u003C\u002Fp>\n\n\n\n\u003Cp>Scientists from the University of Southern California developed a computational method (V-SYNTHES) that allows them to computationally test billions of compounds against a therapeutic target. As described in their Nature paper from 2021, they tested 11 billion theoretical compounds against a cannabinoid receptor (CB2) that marijuana’s active ingredient THC targets. \u003C\u002Fp>\n\n\n\n\u003Cp>V-SYNTHES is now used by research labs and pharmaceutical companies in drug discovery. It’s particularly valuable for screening large chemical libraries against specific targets, helping identify novel drug candidates that may have been overlooked using traditional methods.\u003C\u002Fp>\n\n\n\n\u003Cp>And this is just the beginning! Look at \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fnews.mit.edu\u002F2022\u002Fai-model-finds-potentially-life-saving-drug-molecules-thousand-times-faster-0712\" target=\"_blank\">this announcement\u003C\u002Fa>: “In a paper that will be presented at the International Conference on Machine Learning (ICML), MIT researchers developed a geometric deep-learning model called EquiBind that is 1,200 times faster than one of the fastest existing computational molecular docking models, QuickVina2-W, in successfully binding drug-like molecules to proteins.”\u003C\u002Fp>\n\n\n\n\u003Cp>No genius drug researcher can compete with something being 1,200 times (!) faster than not them, but the previous supercomputer model.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>3. With 3D printing, pharma companies can make personalized medicine a reality \u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Despite being a relatively new technology adopted in healthcare, 3D-printed drugs show great promise. The \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fqz.com\u002F471030\u002Fthe-fda-has-approved-the-first-drug-made-by-a-3d-printer\u002F\" target=\"_blank\">first FDA approval of a 3D-printed pill\u003C\u002Fa> was issued only in 2015, but the technology is already paving the way for personalized medicine. This was, in fact, the conclusion of a 2019 research. The researchers successfully 3D-printed 6 different drugs into a single, multilayered polypill. With this technique, pills of specific doses tailored to individual patients are made possible.\u003C\u002Fp>\n\n\n\n\u003Cp>Medical 3D-printing company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fabrx.co.uk\u002F\" target=\"_blank\">FabRx\u003C\u002Fa> is aggressively working towards this goal. In April 2020, they \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fabrx.co.uk\u002F2020\u002F04\u002F06\u002Ffabrxs-pharmaceutical-3d-printer-for-personalised-medicines-m3dimaker-is-now-available\u002F\" target=\"_blank\">released M3DIMAKER\u003C\u002Fa> – the first pharmaceutical 3D printer to manufacture personalized medicines. In 2024, Gustave Roussy, Europe’s leading oncology hospital, successfully implemented the M3DIMAKER 2 3D drug printing device \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fabs\u002Fpii\u002FS0378517324005404\" target=\"_blank\">for a pioneering clinical trial\u003C\u002Fa>. Focussed on improving adherence and efficacy in breast cancer treatment, the project combines tamoxifen with antidepressants to mitigate treatment side effects. This meant to 3D-print 40,000 units of polypills. The medicines were successfully developed and produced in the clinical pharmacy department of the cancer hospital.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"2213\" height=\"880\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2024\u002F06\u002F3D-printing-drugs-cancer-polypill.jpg\" alt=\"\" class=\"wp-image-56651\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2024\u002F06\u002F3D-printing-drugs-cancer-polypill.jpg 2213w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2024\u002F06\u002F3D-printing-drugs-cancer-polypill-768x305.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2024\u002F06\u002F3D-printing-drugs-cancer-polypill-1536x611.jpg 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2024\u002F06\u002F3D-printing-drugs-cancer-polypill-2048x814.jpg 2048w\" sizes=\"auto, (max-width: 2213px) 100vw, 2213px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Traditionally, pills were manufactured in standard doses and had to be manually adjusted, for example, by crushing or splitting them to fit the dose for children. This method potentially leads to dosage errors or even improper drug use. With 3D printing, this issue is a thing of the past. The printer allows pharmacists to make pills with precise doses for individual patients. “I truly believe that we are one step closer to personalized medicine thanks to the M3DIMAKER,” \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fabrx.co.uk\u002F2020\u002F04\u002F06\u002Ffabrxs-pharmaceutical-3d-printer-for-personalised-medicines-m3dimaker-is-now-available\u002F\" target=\"_blank\">said Dr. Alvaro Goyanes\u003C\u002Fa>, Director of Development at FabRx.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>4. Boosting adherence of chronic care patients with digital pills\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Yearly, lack of adherence to one’s medication amounts to \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.pillsy.com\u002Farticles\u002Fmedication-adherence-stats#:~:text=Today%2C%20medication%20non%2Dadherence%20leads,billion%20in%20avoidable%20healthcare%20costs.\" target=\"_blank\">125,000 deaths and around $300 billion\u003C\u002Fa> in healthcare costs; all of these are in fact preventable. Other reports \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.psqh.com\u002Fanalysis\u002Fthe-impact-of-cost-on-medication-adherence\u002F#:~:text=Some%2050%25%20of%20Americans%20don,U.S.%20healthcare%20spend%20every%20year\" target=\"_blank\">paint an ever grimmer picture\u003C\u002Fa>, estimating a $500 billion impact, with non-adherence showing a significant correlation with the cost of the treatment.\u003C\u002Fp>\n\n\n\n\u003Cp>However, adhering to treatment plans with multiple medications is especially challenging for patients suffering from chronic conditions such as schizophrenia or cardiovascular diseases. To remedy this pressing issue, digital pills can boost adherence while preventing deaths.\u003C\u002Fp>\n\n\n\n\u003Cp>The FDA first approved such a digital pill \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fcontent\u002Fotsuka-proteus-finally-win-fda-approval-sensor-equipped-abilify\" target=\"_blank\">in 2017\u003C\u002Fa> produced by Otsuka Pharmaceutical and Proteus for chronic mental disorders. This pill contains an ingestible sensor, which is a wearable patch sensor and an app track. This allows physicians to monitor a patient’s compliance with the treatment.\u003C\u002Fp>\n\n\n\n\u003Cp>Although Proteus \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fiercebiotech.com\u002Fmedtech\u002Fdigital-pill-developer-proteus-files-for-bankruptcy\" target=\"_blank\">filed for bankruptcy\u003C\u002Fa> in June 2020, the technology it employed isn’t at fault. The digital pill field was born, and there are a number of interesting players. \u003C\u002Fp>\n\n\n\n\u003Cp>Digital health company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fetectrx.com\u002F\" target=\"_blank\">etectRx \u003C\u002Fa>aims to advance patient medication adherence and improve ingestion tracking technology. The company’s flagship product, the ID-Cap System is an ingestible event marker: a gelatin capsule with an ingestible sensor that transmits signals to a wearable reader, which sends the data to a smartphone-based app and secure cloud-based server to enable reliable tracking of ingestion events.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F07\u002F185_tmf-01.png\" alt=\"smart pill drug digital\" class=\"wp-image-29169\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F07\u002F185_tmf-01.png 1920w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F07\u002F185_tmf-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F07\u002F185_tmf-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F07\u002F185_tmf-01-1536x864.png 1536w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Harry Travis, CEO and President of the company told The Medical Futurist \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.patreon.com\u002Fposts\u002Fsmart-pills-are-39593309\" target=\"_blank\">in an interview\u003C\u002Fa> that they had three NIH-funded research studies underway (at the time of the interview), and had completed an HIV-prevention study with Brigham and Women’s Hospital in partnership with The Fenway Institute at Fenway Health in Boston, in which their technology recorded medication ingestions with 98 percent accuracy.\u003C\u002Fp>\n\n\n\n\u003Cp>The pandemic also highlighted the importance of remote control over medication adherence, and many trials moved towards monitoring patients remotely instead of requiring in-person visits to a clinic.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>5. Automation supplements the supply chain with more effective solutions\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>With automation, repetitive manual tasks are a thing of the past. By including robots in drug manufacturing factories, the supply chain gets a boost in effectiveness. These automated machines are rapid and consistent with the task programmed while being cost-effective.\u003C\u002Fp>\n\n\n\n\u003Cp>Such solutions already are in practice in the industry. Denso Robotics supplies \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.densorobotics.com\u002Fproducts\u002Fmedical-pharmaceutical\u002F\" target=\"_blank\">pharmaceutical robots\u003C\u002Fa> for manufacturing processes.\u003C\u002Fp>\n\n\n\n\u003Cp>The iA (formerly Innovation Associates) \u003Ca href=\"https:\u002F\u002Fiarx.com\u002Faddressing-pharmacy-labor-shortages-through-prescription-fulfillment-solutions\u002F\">pharmacy automation solutions\u003C\u002Fa> feature scalable dispensing capacity and advanced data mining capabilities. These functionalities provide valuable insights into efficiency, enabling pharmacists to continuously optimize their use. Automated dispensing systems are becoming increasingly prevalent in pharmacies worldwide. While the exact penetration rates vary by region, industry reports suggest significant growth in recent years, with Europe being a particularly active market for such technologies. Dispensing robots are already employed in \u003Ca href=\"https:\u002F\u002Fthejournalofmhealth.com\u002Fhow-robots-are-changing-community-pharmacy\u002F\">70% of community pharmacies in Denmark\u003C\u002Fa>, while in mainland Europe, \u003Ca href=\"https:\u002F\u002Fwww.p3pharmacy.co.uk\u002F10-things-about-automated-dispensing\">30-40% of pharmacies\u003C\u002Fa> use automated dispensers.\u003C\u002Fp>\n\n\n\n\u003Cp>All in all, robotics in pharma can automate repetitive tasks such as sorting, packaging, and labeling medications, minimizing the risk of human error and freeing up personnel for more complex tasks.\u003C\u002Fp>\n\n\n\n\u003Cp>A growing concern with automation is that of not requiring human assistants, leading to rising unemployment. However, the opposite might be true. A pharmacist in Scotland employed more people after including automated technologies in the pharmacy; the reason being the need for more people to manage the resulting increased turnover with automation. \u003C\u002Fp>\n\n\n\n\u003Cp>Moreover, with mundane, repetitive tasks delegated to robots, human input will be important in responsibilities requiring creativity and problem-solving skills. Technology also lends a hand in these situations. Training of workers can be \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Frobotics-blockchain-redesign-pharma-supply-chain\u002F\" target=\"_blank\">enhanced with augmented reality\u003C\u002Fa> by overlaying useful instructions in the real world. For manual workers dealing with heavy weights or standing for long hours, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fexoskeleton-technology\u002F\" target=\"_blank\">exoskeletons\u003C\u002Fa> provide additional support.\u003C\u002Fp>\n\n\n\n\u003Cp>Another promising technology that can benefit pharma companies in the drug supply process is \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-the-hell-is-blockchain-what-does-it-mean-for-healthcare-and-pharma\u002F\" target=\"_blank\">blockchain\u003C\u002Fa>. \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.ijrte.org\u002Fwp-content\u002Fuploads\u002Fpapers\u002Fv10i1\u002FA57440510121.pdf\" target=\"_blank\">Blockchain-based identification of each box\u003C\u002Fa> provides a secure, immutable ledger for tracking the provenance and movement of pharmaceutical products, ensuring traceability from production to patient delivery​. But we’ve seen other creative ideas, such as printing \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.futurity.org\u002Fcounterfeit-medications-fake-drugs-cyberphysical-watermarks-2711322\u002F\" target=\"_blank\">tiny, edible, all-protein unique watermarks\u003C\u002Fa> on individual pills.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004.png\" alt=\"\" class=\"wp-image-28737\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004.png 1920w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F06\u002Fpicture_004-2048x1152.png 2048w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp>As such, drug companies stand more to gain by integrating automation into their supply chain than by shying away from it.\u003C\u002Fp>\n\n\n\n\u003Cp>As we come to the end of this article, we hope that the topics discussed here have got you interested in learning more about how digital health technologies shape the future of pharma. We again invite you to read our analysis in \u003Cstrong>\u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fleanpub.com\u002Fthefutureofpharma\" target=\"_blank\">our latest e-book on LeanPub\u003C\u002Fa>\u003C\u002Fstrong>. We look forward to your feedback!\u003C\u002Fp>\n",{"rendered":208,"protected":20},"\u003Cp>It is obvious that digital health is poised to bring its disruptive force across the healthcare landscape, and the pharmaceutical industry isn’t immune to the upcoming changes. \u003C\u002Fp>\n",16,48037,{"_acf_changed":20,"footnotes":27},[213,33],7079,[215,216,40,39,217,218,219,220,221,47,222,223,224,225,226,227],1497,642,820,134,839,207,223,568,4979,630,4981,631,4983,[49,229,230,231,232,50],948,949,950,951,[],[235,55,236,237,238,239,240,61,241,63,242,243,244,67,245,246,69,60],2299,3825,1599,3829,1607,4927,4929,4941,1617,4943,4975,1631,[248,14,72,73,74,75,76,249,79,250,251,85,84,252,253,254,255,256,92,257,258,259,260,261,262,93,263,264,265,266,94],"post-28943","category-tmf","tag-ebooks","tag-automation","tag-pharmacogenomics","tag-ai","tag-robots","tag-digital-health","tag-ebook","tag-drug-development","tag-digital-pill","tag-digital-technology","tag-chronic-care","tag-patient-empowerment","tag-proteus","project_category-developers","project_category-educators","project_category-medical-professionals","project_category-patients",{"id":210,"alt_text":268,"caption":27,"description":27,"media_type":97,"media_details":269,"post":133,"source_url":288},"The Future Of Pharma Ebook 2022 edition TMF",{"width":270,"height":271,"file":272,"sizes":273,"image_meta":287},1800,1013,"2022\u002F11\u002F1114_pharma_ebook_2022-header-copy.png",{"medium":274,"large":277,"thumbnail":280,"medium_large":283,"1536x1536":284},{"file":275,"width":105,"height":106,"mime-type":107,"source_url":276},"1114_pharma_ebook_2022-header-copy-370x208.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-copy-370x208.png",{"file":278,"width":111,"height":112,"mime-type":107,"source_url":279},"1114_pharma_ebook_2022-header-copy-768x432.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-copy-768x432.png",{"file":281,"width":116,"height":116,"mime-type":107,"source_url":282},"1114_pharma_ebook_2022-header-copy-150x150.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-copy-150x150.png",{"file":278,"width":111,"height":112,"mime-type":107,"source_url":279},{"file":285,"width":121,"height":122,"mime-type":107,"source_url":286},"1114_pharma_ebook_2022-header-copy-1536x864.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-copy-1536x864.png",{"aperture":125,"credit":27,"camera":27,"caption":27,"created_timestamp":125,"copyright":27,"focal_length":125,"iso":125,"shutter_speed":125,"title":27,"orientation":125},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2022\u002F11\u002F1114_pharma_ebook_2022-header-copy.png",{"cta_type":129,"cta_color":27,"subtitle":27,"related_books":290,"related_posts_footer":293,"related_posts":20,"key_takeaways":297},[135,291,292],52203,34151,[294,295,296],56453,56571,24354,[298,300,302],{"title":299},"\u003Cp>The pharmaceutical industry, once a completely closed world, has been transformed by the technological and cultural revolution of the past decades, with both patients and tech companies starting to connect.\u003C\u002Fp>\n",{"title":301},"\u003Cp>This shift has set the industry on a path toward treatments that are more responsive to patients’ needs, more effective, and more personalized.\u003C\u002Fp>\n",{"title":303},"\u003Cp>The AI revolution is expected to bring new drugs to market faster and cheaper, potentially eliminating the need for animal testing.\u003C\u002Fp>\n",{"yoast_wpseo_title":204,"yoast_wpseo_metadesc":305,"yoast_wpseo_canonical":202},"Digital health is poised to bring its disruptive force across healthcare, and the pharmaceutical industry isn’t immune to the upcoming changes.",{"self":307,"collection":312,"about":314,"author":316,"replies":319,"version-history":322,"predecessor-version":326,"wp:featuredmedia":330,"wp:attachment":333,"wp:term":336,"curies":347},[308],{"href":309,"targetHints":310},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F28943",{"allow":311},[146],[313],{"href":149},[315],{"href":152},[317],{"embeddable":26,"href":318},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F16",[320],{"embeddable":26,"href":321},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=28943",[323],{"count":324,"href":325},43,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F28943\u002Frevisions",[327],{"id":328,"href":329},56889,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F28943\u002Frevisions\u002F56889",[331],{"embeddable":26,"href":332},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F48037",[334],{"href":335},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=28943",[337,339,341,343,345],{"taxonomy":175,"embeddable":26,"href":338},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=28943",{"taxonomy":178,"embeddable":26,"href":340},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=28943",{"taxonomy":181,"embeddable":26,"href":342},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=28943",{"taxonomy":184,"embeddable":26,"href":344},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=28943",{"taxonomy":187,"embeddable":26,"href":346},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=28943",[348],{"name":191,"href":192,"templated":26},[350],{"id":136,"date":351,"date_gmt":352,"guid":353,"modified":355,"modified_gmt":356,"slug":357,"status":13,"type":358,"link":359,"title":360,"content":362,"excerpt":364,"author":23,"featured_media":366,"comment_status":25,"ping_status":25,"template":27,"yst_prominent_words":367,"class_list":368,"better_featured_image":371,"acf":391,"yoast_meta":409,"_links":412},"2020-12-02T08:54:13","2020-12-02T07:54:13",{"rendered":354},"https:\u002F\u002Fapi.medicalfuturist.com\u002F?post_type=book&p=31417","2023-03-12T18:17:41","2023-03-12T17:17:41","invest-in-digital-health","book","https:\u002F\u002Fapi.medicalfuturist.com\u002Fbooks\u002Finvest-in-digital-health\u002F",{"rendered":361},"Invest In Digital Health – The Medical Futurist’s Guide",{"rendered":363,"protected":20},"\n\u003Cp>Artificial Intelligence and Digital Health are booming. In this book, we explain why now it’s a good time to invest in Digital Health and give recommendations on where to invest by looking at the top 24 technological trends we find the most promising.\u003C\u002Fp>\n",{"rendered":365,"protected":20},"\u003Cp>Artificial Intelligence and Digital Health are booming. In this book, we explain why now it’s a good time to invest in Digital Health and give […]\u003C\u002Fp>\n",49965,[69,243,55],[369,358,370,73,75,76],"post-31417","type-book",{"id":366,"alt_text":27,"caption":27,"description":27,"media_type":97,"media_details":372,"post":136,"source_url":390},{"width":373,"height":374,"file":375,"filesize":376,"sizes":377,"image_meta":388},320,413,"2020\u002F12\u002Finvest-in-digital-health.png",69673,{"medium":378,"thumbnail":383},{"file":379,"width":373,"height":380,"mime-type":107,"filesize":381,"source_url":382},"invest-in-digital-health-320x208.png",208,31956,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health-320x208.png",{"file":384,"width":385,"height":385,"mime-type":107,"filesize":386,"source_url":387},"invest-in-digital-health-150x150.png",150,21851,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health-150x150.png",{"aperture":125,"credit":27,"camera":27,"caption":27,"created_timestamp":125,"copyright":27,"focal_length":125,"iso":125,"shutter_speed":125,"title":27,"orientation":125,"keywords":389},[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health.png",{"buy_button_text":392,"leanpub_url":393,"preview":394},"Get it on Leanpub","https:\u002F\u002Fleanpub.com\u002Fdigital-health-investments",[395,397,399,401,403,405,407],{"image":396},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-1-1.png",{"image":398},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-2.png",{"image":400},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-3.png",{"image":402},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-4.png",{"image":404},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-5.png",{"image":406},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-6.png",{"image":408},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002FInvest-In-Digital-Health-Guide-Preview-7.png",{"yoast_wpseo_title":410,"yoast_wpseo_metadesc":411,"yoast_wpseo_canonical":359},"Invest In Digital Health - The Medical Futurist's Guide","Investment in digital health: Digital health investment activity is robust in 2020. Read our book to learn more about investing in digital healthcare",{"self":413,"collection":418,"about":421,"author":424,"replies":426,"wp:featuredmedia":429,"wp:attachment":432,"wp:term":435,"curies":438},[414],{"href":415,"targetHints":416},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook\u002F31417",{"allow":417},[146],[419],{"href":420},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook",[422],{"href":423},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fbook",[425],{"embeddable":26,"href":155},[427],{"embeddable":26,"href":428},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=31417",[430],{"embeddable":26,"href":431},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F49965",[433],{"href":434},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=31417",[436],{"taxonomy":187,"embeddable":26,"href":437},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=31417",[439],{"name":191,"href":192,"templated":26},1786260394481]